1990
DOI: 10.1016/s0950-821x(05)80807-2
|View full text |Cite
|
Sign up to set email alerts
|

Coagulopathy and abdominal aortic aneurism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0
1

Year Published

1993
1993
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(15 citation statements)
references
References 27 publications
0
14
0
1
Order By: Relevance
“…This may lead to consumption of platelets and coagulation factors to such an extent that a subclinical disseminated intravascular coagulation may exist. 26 Thus, the mural thrombus represents a biologically active entity with the ability to trap polymorphonuclear leukocytes, absorb circulating plasma components, and aggregate platelets as well as being implicated as a source of proteolysis and fibrinolytic activity thought to be implicit in AAA progression. 25,27,28 Furthermore, it has been proposed that the abluminal part of the thrombus could play a critical role in the evolution of AAAs through its ability to act as solid catalyst between substrates transported through the thrombus and proteases originating from the arterial wall.…”
Section: Resultsmentioning
confidence: 99%
“…This may lead to consumption of platelets and coagulation factors to such an extent that a subclinical disseminated intravascular coagulation may exist. 26 Thus, the mural thrombus represents a biologically active entity with the ability to trap polymorphonuclear leukocytes, absorb circulating plasma components, and aggregate platelets as well as being implicated as a source of proteolysis and fibrinolytic activity thought to be implicit in AAA progression. 25,27,28 Furthermore, it has been proposed that the abluminal part of the thrombus could play a critical role in the evolution of AAAs through its ability to act as solid catalyst between substrates transported through the thrombus and proteases originating from the arterial wall.…”
Section: Resultsmentioning
confidence: 99%
“…In patients with DIC, local activation of coagulation results in the systemic depletion of coagulation factors and platelets, 1 and the basic principal for treating DIC is anticoagulation therapy, such as heparin. 7,8,11,12 Cummins et al reported that long-term treatment with LMWH could provide good symptomatic control of chronic DIC associated with AAA, 5 and as far as we could ascertain, there is not a great difference between LMWH and UFH. However, subcutaneous injection was ruled out because of the large purpura at the site of injection and so we needed to use a drug that could be administered as a bolus injection.…”
Section: Discussionmentioning
confidence: 60%
“…Haemostatic disorders in patients with AAA are manifested by activation of both the coagulation and fibrinolysis processes. A dominating prothrombotic tendency is found in the plasma of AAA patients, and the place of a degenerative aortic lesion is usually filled with ILT, the thickness of which correlates with the size of AAA [13,14,34]. Under physiological conditions (retained vascular continuity and intact endothelium), a haemostatic system provides free blood flow within the vascular bed.…”
Section: Discussionmentioning
confidence: 99%